We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
29 Aug 2020 - 02 Sep 2020
Virtual Venue

Soft Tissue Ablation Made More Predictable

By HospiMedica International staff writers
Posted on 28 Jul 2014
Print article
Image: Emprint ablation system antenna inserted into a tumor directly through the skin (Photo courtesy of Covidien).
Image: Emprint ablation system antenna inserted into a tumor directly through the skin (Photo courtesy of Covidien).
An advanced ablation system offers physicians predictable results regardless of target location or tissue type.

The Emprint Ablation System with Thermosphere Technology is designed to precisely heat and destroy diseased soft tissue, including nonresectable tumors in the liver, lung, and kidney. The system provides clinicians three kinds of spatial energy control (thermal, field, and wavelength) to create spherical ablation zones regardless of target location, tissue type, or changes in tissue properties during a procedure. The system can be used in different procedure settings, including nonsurgical procedures directly through the skin, minimally invasive surgery (MIS), and open surgery.

The system included a 100 W ablation generator with an intuitive user interface and customizable power settings; an internally cooled percutaneous antenna with single body fiberglass construction (available in short, standard, and long lengths); an ablation pump for efficient antenna cooling to minimize thermal conductivity; and a remote temperature probe to verify tissue temperature in real time and trigger automatic ablation shut off when a preset tissue temperature is achieved. The Emprint Ablation System is a product of Covidien (Dublin, Ireland), and has been approved by the US Food and Drug Administration (FDA).

“Covidien is dedicated to improving patient safety and simplifying procedural options, and this innovative technology enables physicians to deliver precise ablation directly to soft tissue, including liver tumors,” said Chuck Brynelsen, president of early technologies at Covidien. “By providing predictable spherical ablation zones, this technology gives physicians more choices in terms of approach, further simplifying needle placement and saving planning and procedure time.”

Related Links:


Print article



view channel

Siemens to Acquire Varian Medical to Create Comprehensive Cancer Portfolio

Siemens Healthineers (Erlangen, Germany) has entered into an agreement to acquire Varian Medical Systems, Inc. (Palo Alto, CA, USA) that will lead to the creation of a global leader in healthcare with... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.